Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2015-07-28FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Lanoxin (digoxin) submitted by Covis Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter [Phase 3]
Phase 3 trial evaluating prevention of atrial fibrillation after atrial flutter ablation using Inhibition Conversion Enzyme (ICE) has been t…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Risk Profile for Atrial Fibrillation
This is a completed clinical trial update documenting the risk profile associated with atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation [NA]
A completed clinical trial compared minimally invasive surgical treatment versus medical management for patients with atrial fibrillation wh…
-
CLINICAL_TRIALS research · 2015-07-23Clinical Trial Update: ELR Monitoring Against Permanent Pacemaker in Atrial Fibrillation [NA]
This clinical trial update notes an Eastbourne General Hospital study evaluating ELR monitoring for patients with atrial fibrillation; the c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Markers of Paroxysmal Atrial Fibrillation in Esophageal Holter Electrocardiography
A completed clinical trial update evaluating markers of paroxysmal atrial fibrillation detected via esophageal Holter ECG.
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure [Phase 2]
Phase 2 trial of ranolazine for atrial fibrillation and diastolic heart failure was terminated. Results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-07-09Clinical Trial Update: Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population [Phase 1, Phase 2]
Clinical trial update describing ablation for paroxysmal atrial fibrillation using appropriate contact force in a Chinese population (Phase …
-
FDA approval · 2015-07-08FDA Approved: TIKOSYN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Tikosyn (dofetilide) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation [Phase 2]
Phase 2 trial evaluating left atrial appendage occluders after catheter ablation for atrial fibrillation has completed.
-
CLINICAL_TRIALS research · 2015-07-08Clinical Trial Update: Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Patients With Persistent AF [Phase 2]
This document is a Phase 2 clinical trial update evaluating atrial ganglionated plexi ablation with or without conventional pulmonary vein i…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: A Prospective Study of Different Digoxin Treatment Regimens in Egyptian Hospital [Phase 4]
A Phase 4 prospective trial in Egypt compared different digoxin regimens for atrial fibrillation and has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage
A completed study compared the safety and effectiveness of warfarin and dabigatran in patients with atrial fibrillation within the DoD healt…
-
FDA approval · 2015-07-02FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for amiodarone hydrochloride by Advagen Pharma Limited. This action confirms regulatory clearance fo…
-
FDA approval · 2015-07-01FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for sotalol hydrochloride from Apotex Corp., indicating approval of a generic sotalol product.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Evaluation of 5 Days Holter and 30 Days Thumb-ECG for Detection of Atrial Fibrillation in Stroke Patients [NA]
A completed clinical trial evaluated 5-day Holter monitoring and 30-day thumb-ECG for detection of atrial fibrillation in stroke patients.
-
CLINICAL_TRIALS research · 2015-06-23Clinical Trial Update: a Novel Individualized Substrate Modification Approach for the Treatment of Long-standing Persistent Atrial Fibrillation [NA]
Clinical trial update for a novel individualized substrate modification approach to treat long-standing persistent atrial fibrillation, spon…
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Recurrence of Arrhythmias After Pulmonary Veins Isolation Detected by ICM [Phase 4]
Phase 4 clinical trial update analyzing recurrence of arrhythmias after pulmonary vein isolation using an implantable cardiac monitor in pat…
-
FDA approval · 2015-06-16FDA Approved: SOTYLIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SOTYLIZE (sotalol hydrochloride) from Azurity Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2015-06-15Clinical Trial Update: Dabigatran Adherence Pilot Intervention for Patients With Atrial Fibrillation [NA]
A completed clinical trial evaluating a dabigatran adherence intervention for patients with atrial fibrillation; results were posted in 2015…
-
CLINICAL_TRIALS withdrawal · 2015-06-15Clinical Trial Update: Dual Chamber Versus Single Chamber Cardiac Pacing in People 80 Years of Age and Older [NA]
A clinical trial comparing dual-chamber versus single-chamber cardiac pacing in people aged 80 and older has been terminated.
-
CLINICAL_TRIALS withdrawal · 2015-06-15Clinical Trial Update: Atrial Appendage Closure Prospective Observational Study
The prospective observational trial on atrial appendage closure in atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation [Phase 3]
Phase 3 clinical trial comparing chemical versus electrical cardioversion in emergency department patients with acute atrial fibrillation ha…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study [Phase 3]
Phase 3 trial evaluating remote steering and testing with the Vdrive system in Lasso electrophysiology procedures for atrial fibrillation ha…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Reveal® XT Performance Trial (XPECT) [Phase 4]
Phase 4 XPECT trial evaluating the Medtronic Reveal XT device for patients with atrial fibrillation and risk of cardiac arrhythmias has comp…